OP 687
Alternative Names: OP687Latest Information Update: 28 Dec 2021
At a glance
- Originator Outpost Medicine
- Class Irritable bowel syndrome therapies; Urologics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Irritable bowel syndrome; Overactive bladder
Most Recent Events
- 28 Dec 2021 No recent reports of development identified for preclinical development in Irritable-bowel-syndrome in United Kingdom (PO)
- 28 Dec 2021 No recent reports of development identified for preclinical development in Irritable-bowel-syndrome in USA (PO)
- 28 Dec 2021 No recent reports of development identified for preclinical development in Overactive bladder in United Kingdom (PO)